A new FDA-approved daily pill aimed at lowering “bad” cholesterol is drawing attention from doctors and patients looking for another option to bring down high LDL levels. The drug is called Lipfendra, ...

A one-time snip of a key gene lowered heart-clogging cholesterol by about 50% over an entire year with no adverse effects, scientists have reported. The overwhelmingly positive results were found in ...

I’ve received so many questions from readers, clients and a few family members about the recently updated guidelines from the American College of Cardiology and the American Heart Association on ...

Ignite Cycle Executive Director Amy Stanaland, left, and The Wellness Passport Owner Emma Riley, right, are pumped to kick off the 2026 season for The Wellness Passport, with passports on sale now.

As you visit the doctor over the years, you may notice certain numbers in your bloodwork slowly creeping up. Cholesterol, a waxy substance found in every cell of your body, is vital to its functioning ...

"Looking ahead to next quarter, we're expecting a 2% to 4% top line growth" (CFO Nemchenko). Nemchenko said the outlook is "driven by the ramp-up of new store openings and our M&A pipeline" and ...

You’ve probably had a standard lipid panel at a routine physical, since it’s generally recommended every four to six years for healthy adults, and more often for those with heart disease or diabetes.

GREENVILLE, S.C. (FOX Carolina) - A new medication is helping patients lower their cholesterol in a major way. For the first time, the treatment is available in a pill form. The once-daily tablet, ...

WATCH: Miami Head Coach Mario Cristobal’s best sound bites from his press conference ahead of the Hurricanes matchup with Clemson. WATCH: Clemson Football Head Coach Dabo Swinney describes the ...

The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown. By Gina Kolata The Food and Drug Administration approved a daily pill on Thursday ...

FDA approval establishes enlicitide as the first oral PCSK9 inhibitor for low-density lipoprotein cholesterol reduction, positioning it as a daily alternative to injectable PCSK9 agents. The approved ...

A cholesterol test that many Americans don't receive may do a better job of identifying who needs treatment to reduce the risk of heart attacks and strokes, according to new research from Northwestern ...